OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
February 02, 2010
Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.
January 02, 2010
Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.
December 02, 2009
Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
November 02, 2009
The heightened focus on risk raises concerns about delays in approving new drugs.
October 02, 2009
Strict enforcement, new rules, and organizational changes signal an activist tone.
September 02, 2009
Health crises generate support for new vaccines and treatments for diseases found in developing nations.